Note 3 — Initial Public Offering

On February 27, 2026, the Company sold 11,197,131 Units at a price of $10.00 per Unit including the partial exercise of the over-allotment option of 1,197,131 Units granted to the underwriters. Each Unit consists of one ordinary share with $0.0001 par value and one right (the “Public Right”). Each Public Right entitles the holder to receive one-fourth (1/4) of one ordinary share upon the consummation of the Company’s initial Business Combination. The Company will not issue fractional shares upon conversion of the rights, as disclosed in Note 7.

On April 10, 2026, the underwriters notified the Company of their exercise of the over-allotment option in full to purchase an additional 302,869 Units at a price of $10.00 per Unit. The closing of the over-allotment option occurred on April 15, 2026, generating additional gross proceeds of $3,028,690. Simultaneously with the closing of the over-allotment option, the Company consummated the private placement of an aggregate of 3,029 units (the “Private Placement Units”) to the Sponsor, at a price of $10.00 per Private Placement Unit, generating gross proceeds of $30,285. As a result, the Company sold an aggregate of 11,500,000 Public Units in the IPO and over-allotment, generating aggregate gross proceeds of $115,000,000.